Welcome to Tanso Biosciences, a leading provider of functional assays for G-protein-coupling receptors (GPCRs). Our proprietary technology allows for the selective amplification of GPCR-induced signals in reporter cells, providing sensitive and specific readouts for a wide variety of GPCRs. We offer a range of panel options and custom assays to meet the unique needs of our clients, and provide contract research services to pharmaceuticals, biotech companies, food companies, and academia worldwide. We also engage in our own in-house drug discovery projects. Explore our site to learn more about our services and how we can support your research.
Core Business
Drug Discovery Enterprise
We take advantage of our all-around assay technology and engage in drug discovery for orphan GPCRs.
Contract Services
Panel assays, concentration dependence analysis, and other functional assays for > 550 human and mouse GPCRs.
Assay Platform
Uses
- On-target and off-target screening for drug discovery
- Compound profiling
- Strategy development
- In-licensing assessment
- Drug repurposing
Key Features
Potency-Oriented
Characterizes compounds' potency, not affinity, on the G-protein pathways of the target GPCR in various modes
Super-Sensitive
Dramatically and specifically amplifies G-protein-dependent signals
All-Around
All GPCRs are amenable in single assay format, regardless of Gα proteins coupled
Clients & Partners
Here are just a few of our valued clients and partners.
Testimonials
I highly recommend Tanso Biosciences for their assay platform. Its reliability and industry-leading receptor coverage make it a uniquely valuable guide to GPCR drug discovery. We experienced a quick turnaround time as well.
KEN HORNE
CEO, Capacity Bio, CA, USA
Tanso Bio helps us accelerate structure-activity relationship studies.
Researcher, Pharma A
Tanso Bio's assays have revealed key features of our compounds that would otherwise remain unnoticed.
Researcher, Pharma B
Assay Types
Assay Examples
Shown below are a few use cases of our assay platform.
Endocrinol/Metab Panel
TAK-875, an antidiabetic agent, against 48 GPCRs associated with endocrinology and metabolism
Antagonist Mode Conc-Response Analysis
AGTR1 was treated with various concentrations of an antagonist, valsartan, in the presence of angiotensin II.
G12/13
Agonist-induced concentration-dependent activation of LPAR6, a G12/13-coupled receptor
News & Updates
250 Mouse GPCRs Are Available Now
Microsoft for Startups
Disease-Associated GPCR Variants
Video Guide to Order Assays
Registered by HHMI as Vendor
MeSH Headings for GPCRs Untangled for Effective PubMed Searches
Contact Us
Send us a message via the form below or write to us at [email protected].
Ordering Process
Service flow chart
Request a quotation
We hear about the study outline and propose experiments. A non-disclosure agreement is optional.
Place an order
You place an order, ship your compounds to our lab, and pay the fee via bank transfer or by credit card.
Wait
The turnaround time can be as short as two weeks, depending on the study scale and design and the backlog of orders.
Receive the report
You receive the study report in PDF.
